Back to funds
View filing
Pivotal bioVenture Partners Investment Advisor LLC
hedge fundUpdated 28 days agoManaged by Pivotal Bioventure Partners Investment Advisor Llc • Latest filing Q2 2026
Portfolio value
$307.8M
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
2.3%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $242.9M |
| Q2 2023 | $303.3M |
| Q3 2023 | $250.7M |
| Q4 2023 | $394.2M |
| Q1 2024 | $155.6M |
| Q2 2024 | $130.1M |
| Q3 2024 | $168.5M |
| Q4 2024 | $148.1M |
| Q1 2025 | $123.6M |
| Q2 2025 | $161.3M |
| Q3 2025 | $173M |
| Q4 2025 | $258.7M |
| Q1 2026 | $279.8M |
| Q2 2026 | $307.8M |
Top holdings
13 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | P PCVX VAXCYTE INC | $82.9M | 1.43M | 26.92% | — |
| 2 | A ARQT ARCUTIS BIOTHERAPEUTICS INC | $33.2M | 1.27M | 10.78% | — |
| 3 | T TRVI TREVI THERAPEUTICS INC | $32.5M | 1.74M | 10.56% | — |
| 4 | A AVLN AVALYN PHARMACEUTICALS INC | $31.8M | 966.8K | 10.34% | — |
| 5 | E EVMN EVOMMUNE INC | $25.6M | 1.93M | 8.32% | — |
| 6 | M MPLT MAPLIGHT THERAPEUTICS INC | $21.9M | 611.4K | 7.12% | — |
| 7 | O OCSAW OCULIS HOLDING AG | $20.9M | 1.51M | 6.79% | — |
| 8 | ? N/A BIOAGE LABS INC | $16M | 653.4K | 5.20% | — |
| 9 | I IMNM IMMUNOME INC | $15.5M | 732.5K | 5.04% | — |
| 10 | Z ZBIO ZENAS BIOPHARMA INC | $12.5M | 490.8K | 4.05% | — |
| 11 | ? N/A AVALO THERAPEUTICS INC | $8M | 434.0K | 2.61% | — |
| 12 | R RLYB RALLYBIO CORP | $4.8M | 300.6K | 1.56% | — |
| 13 | R RXRX RECURSION PHARMACEUTICALS IN | $2.2M | 595.5K | 0.71% | — |